- Patent Title: Method of treating diabetes mellitus by administration, at specifically defined intervals, of a derivative of a naturally occurring insulin or insulin analogue, the derivative having a prolonged profile of action
-
Application No.: US15810680Application Date: 2017-11-13
-
Publication No.: US10596229B2Publication Date: 2020-03-24
- Inventor: Thue Johansen
- Applicant: Novo Nordisk A/S
- Applicant Address: DK Bagsvaerd
- Assignee: Novo Nordisk A/S
- Current Assignee: Novo Nordisk A/S
- Current Assignee Address: DK Bagsvaerd
- Agent Rosemarie R. Wilk-Orescan
- Priority: EP10189115 20101027; EP11170366 20101027
- Main IPC: A61K38/28
- IPC: A61K38/28 ; C07K14/62

Abstract:
The present invention relates to methods for treatment of a condition or disease where administration of insulin will be of benefit, comprising administering, to a patient in need thereof, effective dosages of an insulin, insulin analogue or derivative thereof, which exhibits a prolonged profile of action, wherein said dosages are administered at intervals of varying length.
Public/Granted literature
- US20180125946A1 Treating Diabetes Melitus Using Insulin Injections Administered With Varying Injection Intervals Public/Granted day:2018-05-10
Information query
IPC分类: